Subscrite to The Heart Rehab
-
Recent Posts
The Heart Rehab on Twitter
Tweets by theheartrehab- ACE inhibitor
- American College of Cardiology
- American Heart Association
- Angioplasty
- Aspirin
- Atrial fibrillation
- Blood pressure
- Bristol-Myers Squibb
- bypass surgery
- C-reactive protein
- Cancer
- cardiac event
- cardiac rehab
- cardiac rehabiliation
- cardiac rehabilitation
- Cardiology
- Cardiopulmonary rehabilitation
- Cardiovascular disease
- Cardiovascular Disorders
- Cholesterol
- Colorectal cancer
- Conditions and Diseases
- Coronary artery bypass surgery
- Coronary artery disease
- Death
- diabetes
- diet
- Duke University Hospital
- Education
- exercise
- fitness
- Food
- Food and Drug Administration
- Health
- HealthDay
- Heart
- heart attack
- Heart disease
- Heart failure
- heart health
- Heart rate
- heart surgery
- high blood pressure
- Hypertension
- Implantable cardioverter-defibrillator
- insurance
- Journal of the American College of Cardiology
- Journal of the American Medical Association
- lifestyle
- lifestyle modification
- Major depressive disorder
- Martha Belury
- Medicine
- Muscle
- Myocardial infarction
- national cardiac rehabilitation week
- New England Journal of Medicine
- Nutrition
- Ohio State University
- physical activity
- referral
- Research
- Risk factor
- Salt
- Skeletal muscle
- smoking
- Statin
- stress
- Stroke
- United States
- University College London
- University of California Los Angeles
- Vitamin
- Weight loss
- workout
Archives
Blogroll
Tag Archives: Food and Drug Administration
Varying CRP levels in ethnic groups may affect statin eligibility, heart risk prediction
Study highlights: * C-reactive protein (CRP) levels vary between ethnically-diverse populations, and are only partly due to known differences in heart risk among these groups. * A single risk level of CRP at 2 mg/L may over or … Continue reading
Boston Scientific heart devices get approval
WASHINGTON (Reuters) – Boston Scientific Corp won U.S. approval on Thursday to promote three of its implanted cardiac devices for broader use among patients with heart failure. The Food and Drug Administration cleared the company’s Cardiac Resynchronization Therapy Defibrillators, or … Continue reading
theheartrehab.wordpress.com 